Inogen Inc
No SEC Form 4 filings for $INGN in the last 30 days.
See all $INGN insider activity →Inogen Inc (INGN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ingn-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Inogen Announces Second Quarter 2026 Financial Results Reported second quarter revenue of $95.1 million Company raises full-year adjusted EBITDA guidance to approximately $4.0 million BEVERLY, Mass., August 6, 2026 -- Inogen,
Inogen Inc (INGN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ingn-ex10_1.htm EX-10.1 EX-10.1 Exhibit 10.1 INOGEN, INC. EMPLOYMENT AND SEVERANCE AGREEMENT This Employment and Severance Agreement (this “ Agreement ”) is made and effective on or before a start date of July 6, 2026 (the “ Effective Date ”), by and between Inogen, Inc
Inogen Inc (INGN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ingn-ex10_1.htm EX-10.1 EX-10.1 Exhibit 10.1 INOGEN, INC. AMENDED AND RESTATED 2023 EQUITY INCENTIVE PLAN 1. Purposes of the Plan . The purposes of this Plan are: • to attract and retain the best available personnel for positions of substantial responsibility, • to prov
Over the past 7 days, alphai's AI scored 1 news story mentioning INGN (Inogen Inc). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent INGN coverage spans financial news, corporate actions and earnings.
Guidance raise plus improved adjusted EBITDA and operating cash flow suggest improving profitability trajectory, supporting a near-term re-rate versus prior expectations.
The filing is primarily governance/compensation disclosure; it may slightly affect perceived management stability and future severance liabilities, but no operational guidance is provided.
This is governance/compensation plan disclosure; it may affect near-term sentiment but provides no operational or financial guidance changes.
Inogen's Q1 2026 revenue exceeded expectations due to international growth, but EPS fell slightly short. The stock responded with a modest increase, indicating cautious optimism. The company's reaffirmed guidance and new product launches suggest potential positive momentum.
Recent insider transactions at Inogen Inc suggest potential confidence from management, with equity grants and stock exercises. However, these actions are typical for compensation and do not necessarily indicate immediate company performance changes.
alphai scores every news story that mentions INGN with an AI model for sentiment and relevance, and aggregates insider trades from Inogen Inc's SEC EDGAR Form 4 filings. Figures refresh continuously.
Inogen Inc (INGN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ingn-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Inogen Announces Second Quarter 2026 Financial Results Reported second quarter revenue of $95.1 million Company raises full-year adjusted EBITDA guidance to approximately $4.0 million BEVERLY, Mass., August 6, 2026 -- Inogen,
4 min readInogen Inc (INGN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ingn-ex10_1.htm EX-10.1 EX-10.1 Exhibit 10.1 INOGEN, INC. EMPLOYMENT AND SEVERANCE AGREEMENT This Employment and Severance Agreement (this “ Agreement ”) is made and effective on or before a start date of July 6, 2026 (the “ Effective Date ”), by and between Inogen, Inc
2 min readInogen Inc (INGN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ingn-ex10_1.htm EX-10.1 EX-10.1 Exhibit 10.1 INOGEN, INC. AMENDED AND RESTATED 2023 EQUITY INCENTIVE PLAN 1. Purposes of the Plan . The purposes of this Plan are: • to attract and retain the best available personnel for positions of substantial responsibility, • to prov
3 min readInogen Inc. (INGN) reported mixed Q1 2026 results, with revenue of $85.1 million ahead of forecasts by 3.34% due to strong international sales growth, while EPS missed predictions at -$0.30 against -$0.29. Despite the EPS miss, the stock saw a modest 0.7% increase in aftermarket trading, reflecting cautious optimism driven by the revenue beat and strategic product launches like the Aurora CPAP mask. The company reaffirms its 2026 revenue guidance, expecting stronger profitability in Q2 and Q3 due to seasonal trends and continued investment in new markets and product innovation.
4 min readInogen Inc's VP and Chief Accounting Officer, Mary E. Wright, reported several equity compensation transactions detailed in a recent Form 4 SEC filing. These included the exercise or conversion of restricted stock units into common stock, grants of common stock, and shares withheld for tax liabilities. A new grant of 8,000 restricted stock units was also awarded, vesting over several years.
2 min readInogen Inc.'s CEO, Kevin Raymond Merrill Smith, received a grant of 90,000 restricted stock units (RSUs) on February 27, 2026, which will vest over three years. He also had performance-based and time-based RSUs vest on March 1, 2026, leading to share acquisitions and subsequent share withholdings to cover tax liabilities. This information was reported in a recent SEC Form 4 filing.
2 min readInogen (INGN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
3 min readINGN stock slid despite a narrower Q3 loss and rising B2B demand, as weaker consumer and rental sales weighed on results.
3 min readInogen (INGN) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
3 min readExpanding product portfolio and high prospects for POC raise optimism for INGN stock.
3 min read
